Xiaochuan Yang

Xiaochuan Yang
Dr. Xiaochuan Yang is a physician scientist with special interest in hematology/oncology research. With a B.S. in Pharmaceutical Sciences from Peking University (2004) and a PhD in Medicinal Chemistry from Georgia State University (2010), both of his thesis topics were focused on small molecular anti-cancer drug development. The evolving curiosity from chemistry innovation to application led him to pursue clinical pharmacology research at Kimmel Cancer Center at Johns Hopkins later. The 3 years postdoctoral research at Hopkins involved detailed studies of Flt3-mutated AML, its targeted and combination therapy, and its potential resistance mechanism against therapy. His work was presented at the 53rd ASH meeting, and resulted in several pulications on journals including Blood, Oncogene, and British Journal of Haematology. In 2013, Dr. Yang was awarded the Rangos Award for Creativity in Cancer Discovery at Johns Hopkins University. Later, Dr. Yang went to Ben Gurion Univeristy of the Negev in Israel for study in medicine and obtained his MD there in 2017. During his medical school, Dr. Yang has actively rotated in the services of Surgical Oncology in Memorial Sloan Kettering Cancer Center and Hematology in NIH Clinical Center. Right now, Dr. Yang is a resident in Internal Medicine at Mount Sinai St Luke’s- Mount Sinai West Hospital Center, and continuing his journey in the frontier of hematology/oncology research., United States